
usd aug pm et
summari compani largest pharmaci health care provid
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
aug pm stock trade
earli began test first
remodel store healthhub texa
store expand health care
servic offer aim help patient
avoid hospit better manag
health upon initi success healthhub
model announc intent
expand healthhub metro area
locat end
also encourag
effort drive engag
custom nationwid expans
carepass subscript program
clinic trial home hemodialysi system
text messag program
debt taken merger
aetna suspend share
repurchas program dividend increas
compani achiev leverag ratio
debt trail ebitda near
commit lower leverag
end strong free cash flow
gener expect gener
billion billion
expect sale rise
billion driven acquisit
share trade
ep significantli
under-valued analysi late
trade low end five-year price-to-earnings
rang multitud
anticip headwind
fail materi rebat elimin
think cvs-aet combin
tremend upsid potenti
aet grow exposur medicar advantag
plan redesign in-stor experi
pharmaci custom grow
array health care servic offer
financi perspect
underwhelm pbm
headwind also transit
year invest heavili
integr aet streamlin health care
deliveri initi digit
health long-term valu perspect
remain optimist share
risk rate price includ integr
difficulti failur improv patient care
increas industri regul suppli chain
target appli forward
pe multipl ep
risk assess reflect compani leadership
posit strong market share rel stabl
 retail drug industri pharmaci benefit
manag pbm somewhat off-set
acquisition-integr risk elev debt level
growth non-tradit competitor
nov ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
gener counsel
corpor overview health corpor oper one largest drug store chain
pharmaci benefit manag base revenu net incom store count drug store offer
prescript drug wide assort gener merchandis includ over-the-counter drug beauti product
cosmet film photo finish servic season merchandis greet card conveni
servic plan design administr formulari manag claim process report
segment retail/ltc long-term care segment pharmaci servic segment pbm
acquisit insur aetna aet also oper one largest insur
 fall health benefit hcb segment establish acquisit
aet acquisit aet also result silverscript busi move hcb segment
acquir pharmaci oper aet consolid pharmaci servic busi
market profil decemb oper retail locat approxim
walk-in health care clinic lead pharmaci benefit manag million plan
member oper state district columbia puerto rico brazil fill
billion prescript billion fill retail/ltc segment account
 retail pharmaci market
pharmaci servic segment provid full rang pharmaci benefit manag pbm servic
includ oper mail order pharmaci specialti pharmaci medicar part servic
formulari manag discount drug purchas agreement busi gener billion
sale billion oper incom part pharmaci servic segment
specialti pharmaci busi oper retail specialti pharmaci store specialti mail order
pharmaci mail servic pharmaci
retail/ltc segment gener revenu billion oper incom million
retail/ltc segment revenu compris pharmaci retail segment revenu
front store revenu front store categori includ over-the-count
drug beauti product cosmet person care product conveni food among
product proprietari brand product account approxim compani front store
revenu also one largest oper retail health care clinic clinic
diagnos treat minor health condit perform health screen monitor chronic condit
hcb segment lead health care benefit provid serv estim million
peopl decemb health benefit segment offer broad rang tradit
voluntari consumer-direct health insur product relat servic includ medic
pharmaci dental behavior health medic manag capabl medicar advantag medicar
administr servic health inform technolog hit product servic
corpor strategi pharmaci servic busi strategi center provid innov tool
strategi well qualiti client servic help improv clinic outcom client plan
member assist better pharmaci manag overal health care cost aim
leverag expertis core pbm servic includ plan design offer administr
formulari manag medicar part servic mail order specialti pharmaci infus servic
diseas manag servic medic spend manag
one key retail pharmaci busi strategi technolog allow focu
constantli improv servic explor way provid person product offer
servic continu leverag digit tool empow custom patient make full
breadth health care pharmaci servic avail anytim anywher also continu
introduc digit tool make easier peopl save time money live healthier live
roll pay nationwid end-to-end mobil payment solut integr
payment prescript pick-up extracar loyalti program one spot checkout
impact major develop agre acquir third largest health insur
aetna aet total enterpris valu billion decemb combin close
late make strateg sens us provid greater abil incent aetna larg
popul health plan particip util caremark mail order system retail store
financi trend sale grew five-year compound annual growth rate compound-annual-growth-rate
billion year end decemb adjust ep grew slightli higher five-year compound-annual-growth-rate
free cash flow measur cash flow oper less capit expenditur billion
billion billion decemb net
debt capit ratio expect compani focu reduc immens free
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
fairli valu
neutral sinc juli technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
outlook health care servic
sub-industri next year posit
base key assumpt
economi current late-stag
econom cycl mean expect
slowdown econom growth mani
firm within sub-industri see
sustain demand servic even
face weaker econom condit
signific advers chang
oper competit environ health
care servic provid sub-industri
recent pressur headlin risk
relat legisl regulatori
propos medicare-for-al amazon
potenti disrupt health sector
elimin rebat believ
headlin unlik evolv
real threat profit health
care servic firm near futur
nonetheless share health care servic
under-perform broader market recent
partial due pressur certain area
laboratori servic provid labcorp
pressur
sustain headwind clinic lab test
manag pbm hurt lower level
drug price inflat increas pressur
third parti payer partial allevi
high util health care servic
firm issu find
suffici qualifi staff think
pressur may account
equiti valuat suggest
potenti upsid
see opportun health care servic
firm address take advantag
recent pressur face
exampl major pbm merg
major insur off-set pressur
notabl acquir aetna
aet ci acquir express script
esrx lab servic provid
opportun acquir smaller lab gain
scale smaller lab like falter
pressur continu signific
back topic headlin risk democrat
took control hous repres
novemb mid-term elect
result chang dynam
washington
republican-domin preced two
appear run medicar
platform would like
lower averag rate health care servic
henc substanti advers impact firm
sub-industri howev think there
almost-zero chanc becom realiti
near futur
anoth headlin risk potenti repeal
afford act instig
judg texa rule
unconstitut case oppon
decis appeal decis
current expect upheld upon
appeal although decis could take
coupl year reach
repeal expect neg impact health
care servic benefit
increas insur coverag past
sever year
year-to-d june health
servic index declin vs
increas
 health servic index
increas vs decreas
base index
five-year market price perform aug
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
medicare-for-al amazon disrupt higher drug price push
share warrant creat entri point follow cvss
recently-issu weak outlook think manag reset expect
enhanc futur upsid view long-term like cvs/aet tie-up
could potenti upsid combin entiti given higher exposur
medicar advantag plan in-stor redesign plan pharmaci
custom forward ep estim share near low end cvss
rang think limit downsid
replac ba high-qual capit appreci portfolio follow
ethiopian plane crash although think alter long-term
prospect ba see chanc increas share volatil short term
news flow relat investig crash ground ba
et cfra maintain strong buy opinion share
corpor lower target
ep estim multipl near low end
rang persist industry-wid drug reimburs
pressur ep vs lower estim
lower ep initi ep
share trade morn like disappoint ep
guidanc guidanc significantli expect
surpris conserv estim critic
transit year year invest heavili integr aet
streamlin health care deliveri initi digit health
weve reduc target price reflect headwind
continu believ share under-valued especi given
compani robust cash flow gener long-term valu creat
cvs-aet merger /kevin huang cfa
analyst research note compani news
et cfra maintain strong buy opinion share
corpor rais target base
multipl ep ep vs
surpass expect due broad-bas out-performance lift
ep pharmaci servic pbm
retail/ltc segment benefit stronger-than-expect prescript
volum growth brand name drug price inflat partial off-set
continu price/reimburs pressur gener drug usag oper
incom health care benefit segment billion
expect remain encourag effort drive higher consum
engag medic adher share retail pharmaci
market expand basi point yoy recent initi
healthhub pilot store carepass program given compani
integr progress expect million synergi ahead
initi expect million /kevin huang cfa
et cfra maintain strong buy opinion share
corpor share pharmaci benefit manag pbm
includ ci insur trade pre-market today
news trump administr end pursuit elimin rebat
collect pbm mostli pass insur
expect elimin rebat sever impact profit
pbm move would certainli caus short-term industri
friction compani would modifi contract process
respons possibl rebat elimin also seem weigh
heavili share pbm past year on-going debat
rise health care price drug industri frequent point pbm
industri key sourc high drug price rebat elimin
tabl expect trump administr turn focu away
pbm back toward drug industri /kevin huang cfa
pm et cfra rais sector overweight
marketweight cfra rais
sector overweight marketweight market valuat
expand sector trade discount histor averag cfra
find opportun within health care sector trade forward
price-to-earnings basi histor averag first quarter
compani health care sector beat sale
earn estim best perform index biotech
pharmaceut compani account market capit
sector drug pipelin approv time reduct activ make
industri attract care histori outperform
season slow period year may octob cfra
forecast sector like disappoint lindsey bell
et cfra reiter strong buy opinion share
corpor lower target
ep estim multipl near low end
rang recent pressur drug reimburs
risk ep vs consensu expect
adjust ep ep
given disappoint initi guidanc surpris see
revis full-year guidanc modestli upward revenu
expand larg aetna acquisit also
increas prescript volum brand name drug price inflat
pharmaci servic retail/ltc segment announc combin
variou product program one enterpris modern initi
aim gener run rate save billion also encourag
hear expand healthhub model three store
et cfra add corp high-qual capit
appreci portfolio think neg sentiment around
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
